Comparison timestamp: 2025-05-18 23:40:38 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/mmwr/preview/mmwrhtml/rr5806a2.htm
Live cdc.gov URL ↗: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5806a2.htm
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/mmwr/preview/mmwrhtml/rr5806a2.htm
Live cdc.gov URL ↗: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5806a2.htm
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/mmwr/preview/mmwrhtml/rr5806a2.htm | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentRecommendations and ReportsJune 12, 2009 / 58(RR06);30-32Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: https://www.cdc.gov/mmwr/preview/mmwrhtml/mmwrq%40cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.Appendix ATerms and Abbreviations Used In This ReportABMG American Board of Medical GeneticsABN Advance beneficiary noticeAccuracy Closeness of the agreement between the result of a measurement and a true value of the measurandACMG American College of Medical GeneticsAllele One version of a gene at a given location (locus) along a chromosomeAMP Association for Molecular PathologyAmplicon Piece of nucleic acid formed as the product of molecular amplificationAmplification In vitro enzymatic replication of a target nucleic acid (e.g., polymerase chain reaction [PCR])ASR Analyte-specific reagentBidirectional sequencing A method used to determine the positions of a selected nucleotide base in a target region on both strands of a denatured duplex nucleic acid polymerCAP College of American PathologistsCDC Centers for Disease Control and PreventionCLIA Clinical Laboratory Improvement Amendments of 1988CLIAC Clinical Laboratory Improvement Advisory CommitteeCLSI Clinical and Laboratory Standards Institute (formerly NCCLS)CMS Centers for Medicare & Medicaid ServicesCompetency assessment Evaluation of a person's ability to perform all aspects of testing, from specimen collection to result reportingControl material A device, material, solution, or lyophilized preparation intended for use in the quality-control processCPT Current Procedural TerminologyCVS Chorionic villus samplingDNA Deoxyribonucleic acid, the molecule that encodes genetic informationDTC Direct to consumerFamily history The genetic relationships and medical history of a family; also referred to as a pedigree when represented in diagram form using standardized symbols and terminologyFDA Food and Drug AdministrationFounder effect The presence of gene mutation in high frequency in a specific population that arises because the gene mutation was present in a single ancestor or small number of ancestors in the founding populationGenetics The study of inheritance patterns of specific traitsGenome The complete genetic content of an organismGenotype The genetic constitution of an organism or cell; also refers to the specific set of alleles inherited at a locusGermline mutation The presence of an altered gene within the egg or sperm (germ cell), such that the altered gene can be passed to subsequent generationsHeterozygote A person with two different alleles at a particular locus, one on each chromosome of a pair, typically with one normal and one abnormal alleleHHS Department of Health and Human ServicesHIPAA Health Insurance Portability and Accountability Act of 1996Homozygote Person with two identical alleles at a particular locus, one on each chromosome of a pairICD International Classification of DiseaseInformed consent process For molecular genetic testing, the process by which a person voluntarily confirms the willingness to participate in a particular test, after having been informed of all aspects of the test that are relevant to the decision to participateLOD Lower limit of detectionModifiers Genetic or environmental factors that might affect the expressivity (the variability of signs or symptoms that occur with a phenotype) of a genetic alterationMutation An alteration in a gene, which might cause a disease, be a benign alteration, or result in a normal variantNewborn screening Testing conducted within days of birth to identify infants at increased risk for specific genetic disorders, allowing education and counseling for parents and treatment for patients to be initiated as soon as possibleNTC No-template controlPedigree A diagram using standard symbols and terminology to indicate the genetic relationships and medical history of a familyPenetrance The proportion of persons with a mutation causing a particular disorder who exhibit clinical symptoms of the disorderPersonalized medicine Approach to medicine involving use of genomic and molecular data to better target health care, facilitate discovery and clinical testing of new products, and determine patient risk for a particular disease or conditionPhenotype The observable physical and biochemical traits resulting from of the expression of a gene; the clinical presentation of a person with a particular genotypePolymerase chain reaction (PCR) A DNA amplification procedure that produces millions of copies of a short segment of DNA through repeated cycles of 1) denaturation, 2) annealing, and 3) elongation; a very common procedure in molecular genetic testing used to generate a sufficient quantity of DNA to perform a test (e.g., sequence analysis or mutation scanning) or as a test itself (e.g., allele-specific amplification or trinucleotide repeat quantification)Positive predictive value The likelihood that a person with a positive test result actually has a particular gene, is affected by the gene, or will develop the diseasePrecision Closeness of agreement between independent test results obtained under stipulated conditionsPrivate mutation A rare, disease-causing mutation occurring in a few familiesProficiency testing An external quality assessment program in which samples are periodically sent to testing sites for analysisQuality assessment A group of activities to monitor and evaluate the entire testing process; used to help ensure that test results are reliable, improve the testing process, and promote good quality testing practicesQuality control Measures taken to detect, reduce, and correct deficiencies in a laboratory's internal analytical process prior to the release of patient results and to improve the quality of the results reported by the laboratoryReagent A substance that produces a chemical or biological reaction with a patient specimen, allowing detection or measurement of the analyte for which the test is designedReference interval Interval between and including the lower reference limit through the upper reference limit of the reference population (e.g., 95% of persons presumed to be healthy [or normal])Reportable range The range of test values over which the relationship between the instrument, kit, or measurement response of the system is shown to be validRNA Ribonucleic acidSACGHS Secretary's Advisory Committee on Genetics, Health, and SocietySequencing A procedure used to determine the order of nucleotides (base sequence) in a DNA or RNA molecule or the order of amino acids in a proteinTargeted mutation analysis Testing for one or more specific mutationsTotal testing process Series of activities or workflow for performing testing; includes three major phases: preanalytic, analytic, and postanalyticUnidirectional workflow The manner in which testing personnel and patient specimens move through the molecular amplification testing process to prevent cross-contaminationVariant Any heritable change in DNA sequenceUse of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.**Questions or messages regarding errors in formatting should be addressed to https://www.cdc.gov/mmwr/preview/mmwrhtml/mmwrq%40cdc.gov.**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Date last reviewed: 5/29/2009HOME | ABOUT MMWR | MMWR SEARCH | DOWNLOADS | RSS | CONTACTPOLICY | DISCLAIMER | ACCESSIBILITYDepartment of HealthMorbidity and Mortality Weekly Report and Human ServicesCenters for Disease Control and Prevention1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.